Lisa Durkin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lisa Durkin

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Journal of Cancer Research and Clinical Oncology|October 18, 2012

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAbDebra T Chao, Mian Su, Sonia Tanlimco, et al.

Leukemia|August 10, 2020

Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism networkXiaorong Gu, Rita Tohme, Benjamin Tomlinson, et al.

American Journal of Clinical Pathology|January 25, 2018

T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology GroupTanu Goyal, Beenu Thakral, Sa A Wang, et al.

Cancer Research|May 17, 2018

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug ConjugatesJames W Purcell, Sonia G Tanlimco, Jonathan Hickson, et al.

The Journal of Clinical Investigation|January 27, 2015

Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromesYogen Saunthararajah, Mikkael Sekeres, Anjali Advani, et al.

Blood|August 4, 2012

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Journal of Cancer Research and Clinical Oncology|October 18, 2012

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAbDebra T Chao, Mian Su, Sonia Tanlimco, et al.

Leukemia|August 10, 2020

Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism networkXiaorong Gu, Rita Tohme, Benjamin Tomlinson, et al.

American Journal of Clinical Pathology|January 25, 2018

T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology GroupTanu Goyal, Beenu Thakral, Sa A Wang, et al.

Cancer Research|May 17, 2018

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug ConjugatesJames W Purcell, Sonia G Tanlimco, Jonathan Hickson, et al.

The Journal of Clinical Investigation|January 27, 2015

Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromesYogen Saunthararajah, Mikkael Sekeres, Anjali Advani, et al.

Blood|August 4, 2012

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.

Pageof 3